Our clinically proven concentric
magnets
are helping athletes to
play harder & recover faster

Our clinically proven concentric
magnets
are helping athletes to
play harder & recover faster

Investing in Active Lifestyles and Healthy Living

Relevium is a publicly traded corporation strategically focused the acquisition of e-retail brands, products and technologies in the health and wellness market, with specific interest in Overall Health, Nutraceuticals, Fitness Nutrition and Cosmeceuticals.

Our Focus

pain relief

Pain avoidance is one of the most important drivers of consumer behavior worldwide. The market for pain relief is estimated to be about $39 billion and is expected to reach $41.5 billion in 2017 with a compound annual growth of over 5%. The primary focus of Relevium in this vertical segment is on wearable devices that reduce musculoskeletal pain caused by injuries or mechanical dysfunction.

recovery

Musculoskeletal injuries such as sprains and strains are among the most common and costly burdens to the medical system and workforce. Direct costs (medical expenses) related to injuries are estimated at $190 billion per year and indirect costs (loss in wages) $120 billion per year. The Integrated Benefits Institute suggest that for every 100 employees the costs to companies’ amounts to $103,000 per year. The primary focus of Relevium in this vertical segment is on wearable technologies that reduce recovery times in treating musculoskeletal injuries.

performance

Traditionally, under the global sports apparel market and encompassing over $135 billion of business in 2012, Performance has widened in scope to include Nutrition and Mind. Driven by a growing fitness consciousness, living better and longer, the need for performance enhancement is expected to drive market growth exponentially. The primary focus of Relevium in this vertical segment is on Nutraceuticals and Wearables that enhance overall performance and reduce recovery time.

Relevium Technologies Inc. Press Releases

Relevium Changes Auditors and Corporate Update

Relevium Technologies Inc. announced today that it has changed auditors and appointed Ernst & Young LLP, Chartered Professional Accountants, as the Company’s new auditor, replacing Nexia Freedman LLP, Chartered Professional Accountants, effective as of the date of October 11, 2017.

read more

Relevium Creates Alliance with Salavenia Nutrition and Biodevas Laboratories to Develop an Exclusiv Line of Phyto and Nutraceuticals for Pets

Relevium Technologies Inc. is pleased to announce the launch of a joint cooperation with Salvenia Nutrition and Biodevas Laboratoires to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to Pet Care owners on a direct to consumer basis. Product and market development initiatives are expected to begin in October of this year with the objective of a preliminary launch by Spring of 2018 as a wholly-owned subsidiary of Relevium.

read more

Our Team

Subscribe To Our Newsletter

You have Successfully Subscribed!